QQ客服 官方微博 反馈留言

	CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O-6-methylguanine DNA methyltransferase expression
	Ji, Ming; Wang, Liyuan; Chen, Ju; Xue, Nina; Wang, Chunyang; Lai, Fangfang; Wang, Rubing; Yu, Shishan; Jin, Jing; Chen, Xiaoguang
	2018
卷号	11页码:3671-3684
关键词	Gli inhibitor chemotherapy lomeguatrib xenograft tumor model
ISSN号	1178-6930
DOI	10.2147/OTT.S163535
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6357666
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Ji, Ming,Wang, Liyuan,Chen, Ju,et al. CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O-6-methylguanine DNA methyltransferase expression[J],2018,11:3671-3684.
APA	Ji, Ming.,Wang, Liyuan.,Chen, Ju.,Xue, Nina.,Wang, Chunyang.,...&Chen, Xiaoguang.(2018).CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O-6-methylguanine DNA methyltransferase expression.,11,3671-3684.
MLA	Ji, Ming,et al."CAT(3), a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O-6-methylguanine DNA methyltransferase expression".11(2018):3671-3684.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。